Ann C. Collier

28.2k total citations · 3 hit papers
256 papers, 14.9k citations indexed

About

Ann C. Collier is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Ann C. Collier has authored 256 papers receiving a total of 14.9k indexed citations (citations by other indexed papers that have themselves been cited), including 192 papers in Infectious Diseases, 189 papers in Virology and 58 papers in Epidemiology. Recurrent topics in Ann C. Collier's work include HIV Research and Treatment (189 papers), HIV/AIDS Research and Interventions (155 papers) and HIV/AIDS drug development and treatment (126 papers). Ann C. Collier is often cited by papers focused on HIV Research and Treatment (189 papers), HIV/AIDS Research and Interventions (155 papers) and HIV/AIDS drug development and treatment (126 papers). Ann C. Collier collaborates with scholars based in United States, South Africa and Canada. Ann C. Collier's co-authors include Lawrence Corey, Robert W. Coombs, Ronald J. Ellis, Justin C. McArthur, Douglas D. Richman, Ronald J. Bosch, Christina M. Marra, David B. Clifford, Igor Grant and Sheila A. Lukehart and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Ann C. Collier

253 papers receiving 14.4k citations

Hit Papers

Antiretroviral-Drug Resistance among Patients Recently In... 1996 2026 2006 2016 2002 1996 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann C. Collier United States 65 9.1k 9.1k 3.3k 3.0k 1.4k 256 14.9k
Robert W. Coombs United States 59 8.9k 1.0× 11.8k 1.3× 5.7k 1.7× 1.8k 0.6× 1.6k 1.1× 235 16.8k
Joep M. A. Lange Netherlands 62 9.3k 1.0× 9.2k 1.0× 3.3k 1.0× 2.0k 0.7× 2.4k 1.7× 293 14.2k
Margaret A. Fischl United States 62 12.5k 1.4× 16.5k 1.8× 6.8k 2.0× 3.4k 1.1× 2.0k 1.5× 268 23.5k
Lisa P. Jacobson United States 65 5.2k 0.6× 6.2k 0.7× 4.0k 1.2× 4.2k 1.4× 2.0k 1.4× 300 14.7k
Matthias Cavassini Switzerland 58 5.0k 0.5× 7.8k 0.9× 3.7k 1.1× 3.0k 1.0× 868 0.6× 367 11.8k
David Katzenstein United States 60 9.5k 1.0× 11.5k 1.3× 3.6k 1.1× 1.7k 0.6× 906 0.6× 281 15.2k
Dominique Costagliola France 69 7.3k 0.8× 9.0k 1.0× 5.6k 1.7× 3.9k 1.3× 1.9k 1.4× 450 17.8k
Brian Gazzard United Kingdom 77 8.9k 1.0× 12.2k 1.3× 7.0k 2.1× 3.3k 1.1× 2.4k 1.7× 494 21.8k
Stefano Vella Italy 53 8.2k 0.9× 10.4k 1.1× 3.5k 1.0× 2.2k 0.8× 711 0.5× 247 13.6k
Adriano Lazzarin Italy 70 10.9k 1.2× 12.2k 1.3× 6.2k 1.9× 3.4k 1.2× 2.8k 2.0× 616 20.6k

Countries citing papers authored by Ann C. Collier

Since Specialization
Citations

This map shows the geographic impact of Ann C. Collier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann C. Collier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann C. Collier more than expected).

Fields of papers citing papers by Ann C. Collier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann C. Collier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann C. Collier. The network helps show where Ann C. Collier may publish in the future.

Co-authorship network of co-authors of Ann C. Collier

This figure shows the co-authorship network connecting the top 25 collaborators of Ann C. Collier. A scholar is included among the top collaborators of Ann C. Collier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann C. Collier. Ann C. Collier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolossváry, Márton, Christopher R. deFilippi, Michael T. Lu, et al.. (2022). Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy. The Journal of Infectious Diseases. 226(10). 1809–1822. 9 indexed citations
2.
Ellis, Ronald J., Robert K. Heaton, Bin Tang, et al.. (2022). Peripheral inflammation and depressed mood independently predict neurocognitive worsening over 12 years. Brain Behavior & Immunity - Health. 21. 100437–100437. 4 indexed citations
3.
Roy, Jason, Michael Z. Levy, Carole L. Wallis, et al.. (2021). Participants Switching to Second-Line Antiretroviral Therapy with Susceptible Virus Display Inferior Adherence and Worse Outcomes: An Observational Analysis. AIDS Patient Care and STDs. 35(12). 467–473. 2 indexed citations
4.
Shireman, Laura M., Lisa A. McConnachie, Josefin Koehn, et al.. (2020). Integration of Computational and Experimental Approaches to Elucidate Mechanisms of First-Pass Lymphatic Drug Sequestration and Long-Acting Pharmacokinetics of the Injectable Triple-HIV Drug Combination TLC-ART 101. Journal of Pharmaceutical Sciences. 109(5). 1789–1801. 16 indexed citations
5.
Saloner, Rowan, Laura M. Campbell, Jessica L. Montoya, et al.. (2019). Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates. Journal of the International Neuropsychological Society. 25(5). 507–519. 25 indexed citations
6.
Stekler, Joanne D., Kenneth Tapia, Janine Maenza, et al.. (2018). No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience. AIDS Research and Human Retroviruses. 34(8). 657–666. 11 indexed citations
7.
Zheng, Lu, Babafemi Taiwo, Rajesh T. Gandhi, et al.. (2014). Factors Associated With CD8+ T-Cell Activation in HIV-1–Infected Patients on Long-term Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(2). 153–160. 26 indexed citations
8.
Hawkins, Natalie, Warren L. Dinges, Yi Liu, et al.. (2013). Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design. PLoS ONE. 8(5). e64405–e64405. 40 indexed citations
9.
Croteau, David, Brookie M. Best, Scott Letendre, et al.. (2012). Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration. AIDS. 26(7). 890–893. 15 indexed citations
10.
Badiee, Jayraan, David J. Moore, J. Hampton Atkinson, et al.. (2011). Lifetime suicidal ideation and attempt are common among HIV+ individuals. Journal of Affective Disorders. 136(3). 993–999. 67 indexed citations
11.
Krishnan, Supriya, Jeffrey T. Schouten, Denise L. Jacobson, et al.. (2011). Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials Analysis. Oncology. 80(1-2). 42–49. 32 indexed citations
12.
Stekler, Joanne D., Sarah Holte, Janine Maenza, et al.. (2008). HIV Dynamics in Seminal Plasma during Primary HIV Infection. AIDS Research and Human Retroviruses. 24(10). 1269–1274. 34 indexed citations
13.
Malhotra, Uma, Ronald J. Bosch, Rui Wang, Ann C. Collier, & M. Juliana McElrath. (2004). Effect of Adjunct Hydroxyurea on Helper T Cell Immunity in HIV Type 1-Infected Patients with Virological Suppression. AIDS Research and Human Retroviruses. 20(8). 807–812. 6 indexed citations
14.
Arduino, Jean Marie, Margaret A. Fischl, Kenneth Stanley, Ann C. Collier, & Donna Spiegelman. (2001). Do HIV Type 1 RNA Levels Provide Additional Prognostic Value to CD4 + T Lymphocyte Counts in Patients with Advanced HIV Type 1 Infection?. AIDS Research and Human Retroviruses. 17(12). 1099–1105. 9 indexed citations
15.
Buchwald, Dedra, et al.. (2000). Use of and Attitudes About Alternative and Complementary Therapies Among Outpatients and Physicians at a Municipal Hospital. The Journal of Alternative and Complementary Medicine. 6(4). 335–343. 42 indexed citations
16.
Brambilla, Donald, Patricia Reichelderfer, James W. Bremer, et al.. (1999). The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. AIDS. 13(16). 2269–2279. 59 indexed citations
17.
Marschner, Ian C., Ann C. Collier, Robert W. Coombs, et al.. (1998). Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy. The Journal of Infectious Diseases. 177(1). 40–47. 182 indexed citations
18.
Marra, Christina M., Cathy W. Critchlow, Edward W. Hook, Ann C. Collier, & Sheila A. Lukehart. (1995). Cerebrospinal Fluid Treponemal Antibodies in Untreated Early Syphilis. Archives of Neurology. 52(1). 68–72. 48 indexed citations
19.
Collier, Ann C.. (1994). Early Intervention in HIV Infection: Where Are We?. AIDS Research and Human Retroviruses. 10(8). 893–899. 4 indexed citations
20.
Agosti, Jan M., Robert W. Coombs, Ann C. Collier, et al.. (1992). A Randomized, Double-Blind, Phase I/II Trial of Tumor Necrosis Factor and Interferon-Gamma for Treatment of AIDS-Related Complex (Protocol 025 from the AIDS Clinical Trials Group). AIDS Research and Human Retroviruses. 8(5). 581–587. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026